Institute of Cancer Research, London

MRI more sensitive than mammogram in detecting disease in younger at-risk women

Published in Telemedicine Business Week, June 15th, 2005

Magnetic resonance imaging (MRI) is almost twice as sensitive as X-ray mammography (XRM) in detecting breast cancer in women at high genetic risk for the disease, study results indicate.

The findings are the result of a national U.K. study (MARIBS) funded by the Medical Research Council, led by Martin Leach of The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, and published online May 16, 2005, in The Lancet.

Past research indicates around 2% of breast cancer is due to the breast cancer gene mutations BRCA1 and BRCA2. Women with one of these gene mutations come from families where there is a strong family risk of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Telemedicine Business Week

Source: Telemedicine Business Week (2005-06-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry